Antipsychotics May Increase Diabetes Risk in Adolescents
the Psychiatry Advisor take:
Children and adolescents who take antipsychotics are at increased risk for developing type 2 diabetes, researchers found.
René Ernst Nielsen, MD, PhD, of Aalborg University Hospital in Aalborg, Denmark, and colleagues examined more than 48,299 youths who were treated for psychiatric illness between 1999 and 2010. Overall, 7,253 were given antipsychotics, and 41,046 were not.
Among youths who were prescribed an antipsychotic medication, 0.72% (95% CI = 0.52% - 0.91%) developed type 2 diabetes, compared to 0.27% (95% CI = 0.22% - 0.32%) not prescribed an antipsychotic, the researchers reported in the Journal of the American Academy of Child & Adolescent Psychiatry.
Developing type 2 diabetes was also more likely if first psychiatric diagnosis was given at an older age (OR=1.19; 95% CI: 1.12-1.27, P< 0.001). In addition, shorter time to onset of diabetes was noted in female youths (OR=4.48; 95% CI: 2.90-6.91, P< 0.001).
“Strict indications for antipsychotic treatment and routine cardiometabolic monitoring are crucial,” the researchers concluded.
Taking Antipsychotics Heightens Kids' Diabetes Risk
Antipsychotics are associated with weight gain and diabetes. The risk and rate of diabetes in children and adolescents treated with antipsychotics is unclear.
A longitudinal register linkage case-control study of diabetes in all psychiatric patients aged <18 years in Denmark was performed from January 1999 through the end of June 2010.
Patients with and without antipsychotic exposure were compared regarding the occurrence of type 2 diabetes, defined as the prescription of oral antidiabetic medication. Regression analyses with type 2 diabetes as the dependent variable were conducted with sex, age, and diagnoses as covariates.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Cardioprotective Treatment May Reduce Adverse Effects in Schizophrenia
- The Challenges of Identifying Biomarkers of Psychiatric Illness
- FDA Approves Powerful New Opioid Despite Criticisms
- Oral Therapy for Suicidal Bipolar Depression Gets Breakthrough Designation
- Impulsivity in Bipolar Disorder, Borderline Personality Disorder, ADHD
- Cannabis Use in Adolescence Associated With Poorer Mental Health Outcomes
- Updates in Borderline Personality Disorder: Your Questions Answered
- Violent Video Games Tied to Physical Aggression
- Shame Drives Suicidal Ideation Among Veterans With PTSD
- Long-term Healthy Diet Associated With Greater Hippocampal Volumes
- FDA to Ban Most Flavored Electronic Cigarettes
- Predictors of CBT Outcomes Identified in Youths With Anxiety Disorders
- Happy Childhood Memories Associated With Better Health
- FDA Launches MyStudies Mobile App in Effort to Increase Access to Real World Patient Data
- Heart Rate Variability Predicts Treatment Response in Anxious Depression